NEWARK, DE / ACCESSWIRE / November 22, 2024 / Laurel Bridge Software, a leader in medical imaging workflow solutions, is ...

The CDC Reports Approximately 385,000 Needlestick and Sharps-Related Injuries Among U.S. Healthcare Workers AnnuallyARLINGTON ...

AG, a best practice platform for mental health and performance, is pleased to announce the appointment of Kevin Reeder as ...

MIAMI, FL / ACCESSWIRE / November 21, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), an emerging leader in age-reversal science, today announced groundbreaking ...

Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it will receive a milestone payment following the pricing approval and launch of FRUZAQLA® (fruquintinib) 1mg/5mg capsules in Japan ...

SACRAMENTO, CA / ACCESSWIRE / November 19, 2024 / Paragon Health IT today announced a collaboration with Dell Technologies.

Scientists have worked out a way of predicting how long a prostate cancer patient will continue to respond to the PARP inhibitor drug, olaparib, according to new research published in the journal ...

To help combat the ongoing opioid crisis, South Beach Detox has introduced a new evidence-based opioid detox program that ...

As a recruiter or hiring manager within the life sciences industry, you’ll know how crucial it is to perfect your candidate ...

VANCOUVER, BC / ACCESSWIRE / November 22, 2024 / Frequency Exchange Corp. ("Frequency Exchange" or the "Company") (TSXV:FREQ)(OTC PINK:FRECF) is pleased to announce former NHL star, Hockey Hall of ...

Biodexa-ClinicalPrograms Biodexa?s clinical programs from left to right: MTX110 for rGBM brain cancer, Tolimidone for Type 1 ...

Dr. Reid Bissonnette, Executive Consultant for Translational Research and Development at Xenetic, discusses positive preclinical data recently presented at the Society for Immunotherapy of Cancer ...